RankAlpha logo
Back to Rankings

ARTV

Artiva BiotherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Bull case assumes positive late-stage signals, a favorable labeling pathway or buyout interest leading to a significant re-rate; limited near-term dilution and execution on partnerships support valuation expansion.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Bear case assumes trial setbacks or need for heavy dilution to fund programs, compressing per-share value; small float and low liquidity can exacerbate selling pressure.
Momentum
86
Value
41
Sentiment
0
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.76 · Bull $7.62 · Bear $2.54Analysis 2025-11-21; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2025-11-21 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-09-11

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions

Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $35.80
Why
Momentum86 · Δ7d +5.3
Value41 · Δ7d -0.0
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • Value remains the lead driver in the composite, 7D delta -0.0.

Contradictions & invalidation

  • Bear case assumes trial setbacks or need for heavy dilution to fund programs, compressing per-share value; small float and low liquidity can exacerbate selling pressure.
  • Mixed signals. Wait for cleaner trend confirmation.

Catalyst clock

No dated catalyst is available.

Partnership or acquisition interest

Lead driver: Value · See fundamentals
Momentum
86
9% active weight
Current posture
7d trendImproving
Δ7d
+5.3
Δ21d
-8.5
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
0
62% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade

Composite grade F. Momentum 86.0 / Value 41.2 / Sentiment 0.0

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-11-21. Scenario method

B+
Bull case
20%
Probability
Target price
$7.62
Analysis reference price unavailable
Analysis 2025-11-21 · RankAlpha Sentiment AI
Most likely
B
Base case
55%
Probability
Target price
$4.76
Analysis reference price unavailable
Analysis 2025-11-21 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$2.54
Analysis reference price unavailable
Analysis 2025-11-21 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$573.97M
Beta
-
Shares Out
48.89M
P/E (TTM) · Derived
-3.4
P/S (TTM)
-
P/FCF (TTM) · Derived
-4.18
Rev YoY
-100.0%
EPS YoY
-27.2%
Gross Margin
-868.5%
Op Margin
-26806.4%
Net Debt
-$97.07M
Current Ratio
24.16
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data